Using automated machine learning to detect kidney anomalies.

Authors

null

Rushil Rawal

Cedars Sinai Medical Center, Los Angeles, CA

Rushil Rawal , John Heard , Peris Castaneda , Joshua Davood , Michael Ahdoot

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Other

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 483)

DOI

10.1200/JCO.2024.42.4_suppl.483

Abstract #

483

Poster Bd #

L2

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Annual Meeting

Artificial intelligence-based prediction model of malignant lung nodules for preoperative planning.

Artificial intelligence-based prediction model of malignant lung nodules for preoperative planning.

First Author: Di Lu

Poster

2024 ASCO Breakthrough

Utility of radiomic features in predicting clinical outcomes in stage II-III pancreatic cancer.

Utility of radiomic features in predicting clinical outcomes in stage II-III pancreatic cancer.

First Author: Haruka Itakura

Poster

2024 ASCO Genitourinary Cancers Symposium

Advancing the drug development process in metastatic prostate cancer through machine learning.

Advancing the drug development process in metastatic prostate cancer through machine learning.

First Author: David Alan Quigley

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.

First Author: Qinmei Xu